Professor Porteus is a physician-scientist who has focused on developing precision genetic engineering strategies to cure hemoglobinopathies and rare genetic diseases of the blood and immune system. He is the Director of the Stanford Center for Definitive and Curative Medicine and is the President-Elect of the American Society of Gene and Cell Therapy (ASGCT). In addition to his academic work, he has been involved in the founding of several biotechnology companies including CRISPR Therapeutics and Kamau Therapeutic and is a scientific advisor to several more.
